Opus Genetics (IRD) said that the FDA has granted Fast Track designation for Phentolamine Ophthalmic Solution 0.75%, reported ...

FORT WAYNE, Ind., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (Nasdaq: VRA) (the "Company”) today announced that it ...

Opus Genetics (IRD) announced completion of enrollment in the VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% ...

FDA Fast Track Designation granted for Phentolamine Ophthalmic Solution 0.75% as treatment of significant chronic night ...

A Pinellas County mom is pushing for more accessible medical food for her 4-year-old son diagnosed with a rare metabolic ...

WISN 12 News is celebrating Black History, highlighting important facts and figures each day of Black History Month.

The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist being investigated to reduce pupil size, and APX3330, a novel ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month ...

Few men use the most effective erection drugs because they must be self-injected into the penis. Few men are willing, but those who do usually like the results.

The patient's blood pressure improved with treatment using phentolamine and phenoxybenzamine. During hospitalization, a femoral vein puncture was performed, and an intravenous catheter was placed to ...